Working… Menu

Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study) (ConCoVid-19)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04342182
Recruitment Status : Active, not recruiting
First Posted : April 10, 2020
Last Update Posted : November 16, 2020
Sanquin Plasma Products BV
Information provided by (Responsible Party):
Bart Rijnders, Erasmus Medical Center